Subscribe or Manage Preferences

Since 2004, the American Pharmacists Association has designated October as American Pharmacists Month. This awareness month provides opportunities to promote the pharmacy profession, and to acknowledge the involvement of pharmacy personnel in supporting positive health outcomes and improving patient care.
In March 2015, the US Food and Drug Administration (FDA) approved filgrastim-sndz (Zarxio), a biosimilar to filgrastim (Neupogen), representing the first biosimilar in the United States.

Results 1 - 2 of 2
  • American Health & Drug Benefits
  • The Journal of Hematology Oncology Pharmacy
  • Lynx CME
  • The Oncology Pharmacist

Search